Suppression of tumour formation by a human sCD44 fusion protein has again been demonstrated lately [221], and a soluble CD44-immunoglobulin fusion protein was able to block the migration of a CD44H-transfected human melanoma cell line across a hyaluronate-coated surface [222]. This evidence concerns the gene CD44 and neoplasm.